After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Recently, Yahoo Finance discussed the stock, revealing that Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NYSE-listed company operates within the Diagnostics & Research industry segment, falling under the Healthcare sector. The current market capitalization of Danaher Corp. is $170.73B. A total of 3.24 million shares were traded on the day, compared to an average of 3.06M shares.
Insider Activity
Insider trades can also provide insight into a stock’s future direction. During the recent three months, DHR has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 36 BUYs and 35 SELLs from insiders. Insiders purchased 245,523 shares during that period but sold 121,781.
In the most recent transaction, Gutierrez-Ramos Jose-Carlos sold 590 shares of DHR for 250.54 per share on Aug 21. After the transaction, the SVP, Chief Science Officer now owns 6,939 company shares. In a previous transaction on Jul 28, Raskas Daniel sold 11,213 shares at 260.65 per share. DHR shares that SVP – Corporate Development owns now total 38,288.
Among the insiders who sold shares, FILLER LINDA disposed of 10,190 shares on Jul 28 at a per-share price of $260.25. This resulted in the Director holding 38,152 shares of DHR after the transaction. In another insider transaction, Weidemanis Joakim sold 22,439 shares at $263.42 per share on Jul 26. Company shares held by the Executive Vice President now total 88,689.
Dividend
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. Danaher Corp. pays an annual dividend of $0.94, resulting in a dividend yield of 0.41%, and it has a price to earnings (P/E) ratio of 29.24. DHR’s most recent ex-dividend date was 12/28/2023 when it declared a $0.24 quarterly dividend that was paid in cash on 1/26/2024. Previously, the company paid the dividend on 10/27/2023 with an ex-dividend date of 10/11/2023. The DHR stock dividend was $0.27 per share in cash.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for DHR in the last 3 months, the mean price target is $241.86 with high estimates of $270.00 and low estimates of $205.00. In terms of 52-week highs and lows, DHR has a high of $247.59 and a low of $182.09.
As of this writing, DHR has an earnings estimate of $1.88 per share for the current quarter. EPS was calculated based on a consensus of 20 estimates, with a high estimate of $1.98 per share and a lower estimate of $1.8. The company reported an EPS of $2.05 in the last quarter, which was 2.00% higher than expectations of $2.01.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. DHR’s latest balance sheet shows that the firm has $2.59B in Cash & Short Term Investments as of fiscal 2021. There were $23.27B in debt and $8.14B in liabilities at the time. Its Book Value Per Share was $70.93, while its Total Shareholder’s Equity was $45.18B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DHR is Buy with a score of 4.40.
